Literature DB >> 12892559

Structural basis for UCN-01 (7-hydroxystaurosporine) specificity and PDK1 (3-phosphoinositide-dependent protein kinase-1) inhibition.

David Komander1, Gursant S Kular, Jennifer Bain, Matthew Elliott, Dario R Alessi, Daan M F Van Aalten.   

Abstract

PDK1 (3-phosphoinositide-dependent protein kinase-1) is a member of the AGC (cAMP-dependent, cGMP-dependent, protein kinase C) family of protein kinases, and has a key role in insulin and growth-factor signalling through phosphorylation and subsequent activation of a number of other AGC kinase family members, such as protein kinase B. The staurosporine derivative UCN-01 (7-hydroxystaurosporine) has been reported to be a potent inhibitor for PDK1, and is currently undergoing clinical trials for the treatment of cancer. Here, we report the crystal structures of staurosporine and UCN-01 in complex with the kinase domain of PDK1. We show that, although staurosporine and UCN-01 interact with the PDK1 active site in an overall similar manner, the UCN-01 7-hydroxy group, which is not present in staurosporine, generates direct and water-mediated hydrogen bonds with active-site residues. Inhibition data from UCN-01 tested against a panel of 29 different kinases show a different pattern of inhibition compared with staurosporine. We discuss how these differences in inhibition could be attributed to specific interactions with the additional 7-hydroxy group, as well as the size of the 7-hydroxy-group-binding pocket. This information could lead to opportunities for structure-based optimization of PDK1 inhibitors.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12892559      PMCID: PMC1223700          DOI: 10.1042/BJ20031119

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

1.  The packing density in proteins: standard radii and volumes.

Authors:  J Tsai; R Taylor; C Chothia; M Gerstein
Journal:  J Mol Biol       Date:  1999-07-02       Impact factor: 5.469

2.  Discovery of PDK1, one of the missing links in insulin signal transduction. Colworth Medal Lecture.

Authors:  D R Alessi
Journal:  Biochem Soc Trans       Date:  2001-05       Impact factor: 5.407

3.  T-Coffee: A novel method for fast and accurate multiple sequence alignment.

Authors:  C Notredame; D G Higgins; J Heringa
Journal:  J Mol Biol       Date:  2000-09-08       Impact factor: 5.469

4.  WHAT IF: a molecular modeling and drug design program.

Authors:  G Vriend
Journal:  J Mol Graph       Date:  1990-03

5.  Positioning hydrogen atoms by optimizing hydrogen-bond networks in protein structures.

Authors:  R W Hooft; C Sander; G Vriend
Journal:  Proteins       Date:  1996-12

Review 6.  Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases.

Authors:  U T Rüegg; G M Burgess
Journal:  Trends Pharmacol Sci       Date:  1989-06       Impact factor: 14.819

7.  The structure of phosphorylated p38gamma is monomeric and reveals a conserved activation-loop conformation.

Authors:  S Bellon; M J Fitzgibbon; T Fox; H M Hsiao; K P Wilson
Journal:  Structure       Date:  1999-09-15       Impact factor: 5.006

Review 8.  Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction.

Authors:  M Frödin; S Gammeltoft
Journal:  Mol Cell Endocrinol       Date:  1999-05-25       Impact factor: 4.102

Review 9.  The cell cycle as a target for cancer therapy: basic and clinical findings with the small molecule inhibitors flavopiridol and UCN-01.

Authors:  Adrian M Senderowicz
Journal:  Oncologist       Date:  2002

10.  3-Phosphoinositide-dependent protein kinase-1 (PDK1): structural and functional homology with the Drosophila DSTPK61 kinase.

Authors:  D R Alessi; M Deak; A Casamayor; F B Caudwell; N Morrice; D G Norman; P Gaffney; C B Reese; C N MacDougall; D Harbison; A Ashworth; M Bownes
Journal:  Curr Biol       Date:  1997-10-01       Impact factor: 10.834

View more
  34 in total

1.  Poly(ADP-ribose) polymerase 1 modulates the lethality of CHK1 inhibitors in mammary tumors.

Authors:  Yong Tang; Hossein A Hamed; Andrew Poklepovic; Yun Dai; Steven Grant; Paul Dent
Journal:  Mol Pharmacol       Date:  2012-05-17       Impact factor: 4.436

Review 2.  Role of the PI3K/AKT and mTOR signaling pathways in acute myeloid leukemia.

Authors:  Sophie Park; Nicolas Chapuis; Jérôme Tamburini; Valérie Bardet; Pascale Cornillet-Lefebvre; Lise Willems; Alexa Green; Patrick Mayeux; Catherine Lacombe; Didier Bouscary
Journal:  Haematologica       Date:  2009-11-30       Impact factor: 9.941

3.  Pharmacodynamics of cytarabine alone and in combination with 7-hydroxystaurosporine (UCN-01) in AML blasts in vitro and during a clinical trial.

Authors:  Deepa Sampath; Jorge Cortes; Zeev Estrov; Min Du; Zheng Shi; Michael Andreeff; Varsha Gandhi; William Plunkett
Journal:  Blood       Date:  2005-11-17       Impact factor: 22.113

4.  Cellular pharmacology of protein kinase Mζ (PKMζ) contrasts with its in vitro profile: implications for PKMζ as a mediator of memory.

Authors:  Alyssa X Wu-Zhang; Cicely L Schramm; Sadegh Nabavi; Roberto Malinow; Alexandra C Newton
Journal:  J Biol Chem       Date:  2012-02-29       Impact factor: 5.157

5.  Metabolic-stress-induced rearrangement of the 14-3-3ζ interactome promotes autophagy via a ULK1- and AMPK-regulated 14-3-3ζ interaction with phosphorylated Atg9.

Authors:  Vajira K Weerasekara; David J Panek; David G Broadbent; Jeffrey B Mortenson; Andrew D Mathis; Gideon N Logan; John T Prince; David M Thomson; J Will Thompson; Joshua L Andersen
Journal:  Mol Cell Biol       Date:  2014-09-29       Impact factor: 4.272

6.  Simultaneous exposure of transformed cells to SRC family inhibitors and CHK1 inhibitors causes cell death.

Authors:  Clint Mitchell; Hossein A Hamed; Nichola Cruickshanks; Yong Tang; M Danielle Bareford; Nissan Hubbard; Gary Tye; Adly Yacoub; Yun Dai; Steven Grant; Paul Dent
Journal:  Cancer Biol Ther       Date:  2011-08-01       Impact factor: 4.742

7.  Genetic and pharmacological inhibition of PDK1 in cancer cells: characterization of a selective allosteric kinase inhibitor.

Authors:  Kumiko Nagashima; Stuart D Shumway; Sriram Sathyanarayanan; Albert H Chen; Brian Dolinski; Youyuan Xu; Heike Keilhack; Thi Nguyen; Maciej Wiznerowicz; Lixia Li; Bart A Lutterbach; An Chi; Cloud Paweletz; Timothy Allison; Youwei Yan; Sanjeev K Munshi; Anke Klippel; Manfred Kraus; Ekaterina V Bobkova; Sujal Deshmukh; Zangwei Xu; Uwe Mueller; Alexander A Szewczak; Bo-Sheng Pan; Victoria Richon; Roy Pollock; Peter Blume-Jensen; Alan Northrup; Jannik N Andersen
Journal:  J Biol Chem       Date:  2010-11-30       Impact factor: 5.157

8.  Binding of BIS like and other ligands with the GSK-3β kinase: a combined docking and MM-PBSA study.

Authors:  Nihar R Jena
Journal:  J Mol Model       Date:  2011-05-11       Impact factor: 1.810

9.  Matching biochemical and functional efficacies confirm ZIP as a potent competitive inhibitor of PKMζ in neurons.

Authors:  Yudong Yao; Charles Shao; Desingarao Jothianandan; Andrew Tcherepanov; Harel Shouval; Todd Charlton Sacktor
Journal:  Neuropharmacology       Date:  2012-07-27       Impact factor: 5.250

10.  PDK1 regulates chemotaxis in human neutrophils.

Authors:  M Yagi; A Kantarci; T Iwata; K Omori; S Ayilavarapu; K Ito; H Hasturk; T E Van Dyke
Journal:  J Dent Res       Date:  2009-11-05       Impact factor: 6.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.